{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:53:09Z","timestamp":1786992789225,"version":"build-2736575974"},"reference-count":54,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-cardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jjcc.2025.12.004","type":"journal-article","created":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T16:10:01Z","timestamp":1765642201000},"page":"109-115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Watchman FLX versus Amplatzer amulet for percutaneous left atrial appendage occlusion: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"88","author":[{"given":"Vinicius Bittar","family":"de Pontes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro E.P.","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Felix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alleh","family":"Nogueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana R.C.","family":"Clemente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Gastaldelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Preda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Garot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jjcc.2025.12.004_bb0005","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.005155","article-title":"Temporal trends in incidence, prevalence, and mortality of atrial fibrillation in primary care","volume":"6","author":"Lane","year":"2017","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.jjcc.2025.12.004_bb0010","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0003-4975(95)00887-X","article-title":"Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation","volume":"61","author":"Blackshear","year":"1996","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.jjcc.2025.12.004_bb0015","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/j.ijcard.2012.12.093","article-title":"Atrial fibrillation: profile and burden of an evolving epidemic in the 21st century","volume":"167","author":"Ball","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.jjcc.2025.12.004_bb0020","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jacc.2023.08.017","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"83","author":"Joglar","year":"2024","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.jjcc.2025.12.004_bb0025","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.jcin.2023.01.011","article-title":"SCAI\/HRS expert consensus statement on transcatheter left atrial appendage closure","volume":"16","author":"Saw","year":"2023","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.jjcc.2025.12.004_bb0030","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1016\/j.jacc.2020.04.067","article-title":"Left atrial appendage closure versus direct oral anticoagulants in high-risk patients with atrial fibrillation","volume":"75","author":"Osmancik","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.jjcc.2025.12.004_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2014.04.029","article-title":"Prospective randomized evaluation of the Watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial","volume":"64","author":"Holmes","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.jjcc.2025.12.004_bb0040","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jjcc.2025.01.014","article-title":"Current evidence and indications for left atrial appendage closure","volume":"85","author":"Shinohara","year":"2025","journal-title":"J. Cardiol."},{"key":"10.1016\/j.jjcc.2025.12.004_bb0045","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1161\/CIRCULATIONAHA.121.057063","article-title":"Amplatzer Amulet left atrial appendage occluder versus Watchman device for stroke prophylaxis (Amulet IDE): A randomized, controlled trial","volume":"144","author":"Lakkireddy","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2025.12.004_bb0050","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.hrthm.2022.02.007","article-title":"Procedural and short-term follow-up outcomes of Amplatzer Amulet occluder versus Watchman FLX device: A meta-analysis","volume":"19","author":"Della Rocca","year":"2022","journal-title":"Heart Rhythm."},{"key":"10.1016\/j.jjcc.2025.12.004_bb0055","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.jjcc.2025.12.004_bb0060","series-title":"Cochrane handbook for systematic reviews of interventions","author":"Higgins","year":"2009"},{"key":"10.1016\/j.jjcc.2025.12.004_bb0065","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/j.jcin.2024.04.050","article-title":"Position statement on cardiac computed tomography following left atrial appendage occlusion","volume":"17","author":"Korsholm","year":"2024","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.jjcc.2025.12.004_bb0070","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1016\/j.jcin.2023.10.046","article-title":"Device-related thrombus after left atrial appendage occlusion: clinical impact, predictors, classification, and management","volume":"16","author":"Alkhouli","year":"2023","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.jjcc.2025.12.004_bb0075","first-page":"4","article-title":"Percutaneous left atrial appendage occlusion: the Munich consensus document on definitions, endpoints, and data collection requirements for clinical studies","volume":"19","author":"Tzikas","year":"2017","journal-title":"Europace"},{"key":"10.1016\/j.jjcc.2025.12.004_bb0080","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.4244\/EIJY19M08_01","article-title":"EHRA\/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion - An update","volume":"15","author":"Glikson","year":"2020","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jjcc.2025.12.004_bb0085","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.jjcc.2025.12.004_bb0090","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.jjcc.2025.12.004_bb0095","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1161\/CIRCULATIONAHA.121.057859","article-title":"Amulet or Watchman device for percutaneous left atrial appendage closure: Primary results of the SWISS-APERO randomized clinical trial","volume":"145","author":"Galea","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2025.12.004_bb0100","doi-asserted-by":"crossref","DOI":"10.3390\/jcdd11060158","article-title":"Comparative assessment of percutaneous left-atrial appendage occlusion (LAAO) devices-a single center cohort study","volume":"11","author":"Kayvanpour","year":"2024","journal-title":"J Cardiovasc Dev Dis"},{"key":"10.1016\/j.jjcc.2025.12.004_bb0105","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s10840-022-01336-4","article-title":"Left atrial appendage sealing performance of the Amplatzer Amulet and Watchman FLX device","volume":"66","author":"Korsholm","year":"2023","journal-title":"J. Interv. Card. Electrophysiol."},{"key":"10.1016\/j.jjcc.2025.12.004_bb0110","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ijcard.2021.09.051","article-title":"Long-term outcome of left atrial appendage occlusion with multiple devices","volume":"344","author":"Radinovic","year":"2021","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.jjcc.2025.12.004_bb0115","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s10840-025-02011-0","article-title":"Quantitative considerations for choosing between Amulet and Watchman FLX and management of device related complications","volume":"68","author":"Kushnir","year":"2025","journal-title":"J. Interv. Card. Electrophysiol."},{"key":"10.1016\/j.jjcc.2025.12.004_bb0120","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jacc.2025.03.535","article-title":"3-year clinical outcomes comparing the Amulet vs Watchman FLX for left atrial appendage closure in patients with atrial fibrillation: results from the SWISS-APERO randomized clinical trial","volume":"86","author":"Galea","year":"2025","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.jjcc.2025.12.004_bb0125","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.jjcc.2025.12.004_bb0130","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/j.jacep.2018.09.007","article-title":"Incidence and clinical impact of device-related thrombus following percutaneous left atrial appendage occlusion: A meta-analysis","volume":"4","author":"Alkhouli","year":"2018","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.jjcc.2025.12.004_bb0135","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.hrthm.2022.02.011","article-title":"The ALSTER-FLX Registry: 3-Month outcomes after left atrial appendage occlusion using a next-generation device, a matched-pair analysis to EWOLUTION","volume":"19","author":"Paitazoglou","year":"2022","journal-title":"Heart Rhythm."},{"key":"10.1016\/j.jjcc.2025.12.004_bb0140","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1253\/circj.CJ-24-0062","article-title":"Comparative data of procedural and midterm outcomes in patients who underwent percutaneous left atrial appendage closure between the WATCHMAN FLX and WATCHMAN 2.5 devices \u2014 Insight from the OCEAN-LAAC registry \u2014","volume":"88","author":"Nakashima","year":"2024","journal-title":"Circ. J."},{"key":"10.1016\/j.jjcc.2025.12.004_bb0145","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1111\/jce.16729","article-title":"Outcomes of left atrial appendage occlusion treatment with Amulet after unsuccessful Watchman FLX device: A multicenter observational study","volume":"36","author":"Bagga","year":"2025","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"10.1016\/j.jjcc.2025.12.004_bb0150","first-page":"2084","article-title":"Comparison of flow dynamics after left atrial appendage occlusion with the Watchman FLX versus Amulet devices: Implications for device-related thrombosis","volume":"106","author":"Bshennaty","year":"2025","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"10.1016\/j.jjcc.2025.12.004_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2021.10.023","article-title":"4-year outcomes after left atrial appendage closure versus nonwarfarin oral anticoagulation for atrial fibrillation","volume":"79","author":"Osmancik","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.jjcc.2025.12.004_bb0160","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jjcc.2023.09.010","article-title":"Initial results of transcatheter modification of left atrial appendage by obliteration with device in patients with nonvalvular atrial fibrillation: Real-world data from the TERMINATOR registry","volume":"83","author":"Hara","year":"2024","journal-title":"J. Cardiol."},{"key":"10.1016\/j.jjcc.2025.12.004_bb0165","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jjcc.2023.07.015","article-title":"5-year stroke rates in nonvalvular atrial fibrillation after watchman compared to direct oral anticoagulants","volume":"83","author":"Khalid","year":"2024","journal-title":"J. Cardiol."},{"key":"10.1016\/j.jjcc.2025.12.004_bb0170","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.jcin.2024.01.310","article-title":"Pericardial effusion after left atrial appendage closure: Timing, predictors, and clinical impact","volume":"17","author":"Galea","year":"2024","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.jjcc.2025.12.004_bb0175","first-page":"128","article-title":"Embolization of left atrial appendage closure devices: A systematic review of cases reported with the watchman device and the amplatzer cardiac plug","volume":"86","author":"Aminian","year":"2015","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"10.1016\/j.jjcc.2025.12.004_bb0180","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jcin.2013.11.010","article-title":"Percutaneous left atrial appendage occlusion for stroke prophylaxis in nonvalvular atrial fibrillation: a systematic review and analysis of observational studies","volume":"7","author":"Bajaj","year":"2014","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.jjcc.2025.12.004_bb0185","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.4022\/jafib.2516","article-title":"Left atrial appendage occlusion device embolization (the LAAODE study): understanding the timing and clinical consequences from a worldwide experience","volume":"13","author":"Murtaza","year":"2021","journal-title":"J Atr Fibrillation"},{"key":"10.1016\/j.jjcc.2025.12.004_bb0190","article-title":"Comparison between Amulet and Watchman left atrial appendage closure devices: A real-world, single center experience","volume":"37","author":"Saad","year":"2021","journal-title":"Int. J. Cardiol. Heart. Vasc."},{"key":"10.1016\/j.jjcc.2025.12.004_bb0195","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jcin.2020.10.034","article-title":"Peridevice leak following Amplatzer left atrial appendage occlusion: Cardiac computed tomography classification and clinical outcomes","volume":"14","author":"Korsholm","year":"2021","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.jjcc.2025.12.004_bb0200","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/eurheartj\/ehad828","article-title":"Residual leaks following percutaneous left atrial appendage occlusion and outcomes: a meta-analysis","volume":"45","author":"Samaras","year":"2024","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.jjcc.2025.12.004_bb0205","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.jacep.2020.06.028","article-title":"The Watchman FLX device: first European experience and feasibility of intracardiac echocardiography to guide implantation","volume":"6","author":"Korsholm","year":"2020","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.jjcc.2025.12.004_bb0210","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1016\/j.jcin.2020.06.056","article-title":"Procedural and short-term results with the new Watchman FLX left atrial appendage occlusion device","volume":"13","author":"Cruz-Gonz\u00e1lez","year":"2020","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.jjcc.2025.12.004_bb0215","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.jacep.2022.03.001","article-title":"Clinical impact of residual leaks following left atrial appendage occlusion: Insights from the NCDR LAAO Registry","volume":"8","author":"Alkhouli","year":"2022","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.jjcc.2025.12.004_bb0220","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/j.jcin.2022.09.001","article-title":"Peridevice leak after transcatheter left atrial appendage occlusion: An analysis of the Amulet IDE Trial","volume":"15","author":"Price","year":"2022","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.jjcc.2025.12.004_bb0225","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.jacc.2022.04.062","article-title":"Impact of peridevice leak on 5-year outcomes after left atrial appendage closure","volume":"80","author":"Dukkipati","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.jjcc.2025.12.004_bb0230","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1161\/CIRCULATIONAHA.110.976449","article-title":"Safety of percutaneous left atrial appendage closure: Results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry","volume":"123","author":"Reddy","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2025.12.004_bb0235","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1161\/CIRCULATIONAHA.118.035090","article-title":"Device-related thrombus after left atrial appendage closure: Incidence, predictors, and outcomes","volume":"138","author":"Dukkipati","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2025.12.004_bb0240","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0140-6736(09)61343-X","article-title":"Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial","volume":"374","author":"Holmes","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jjcc.2025.12.004_bb0245","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.amjcard.2016.01.039","article-title":"Assessment of device-related thrombus and associated clinical outcomes with the WATCHMAN left atrial appendage closure device for embolic protection in patients with atrial fibrillation (from the PROTECT-AF Trial)","volume":"117","author":"Main","year":"2016","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.jjcc.2025.12.004_bb0250","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1007\/s11239-020-02205-5","article-title":"Detailed thrombogenicity phenotyping and 1 year outcomes in patients undergoing WATCHMAN implantation: (TARGET-WATCHMAN) a case-control study","volume":"50","author":"Sherwood","year":"2020","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.jjcc.2025.12.004_bb0255","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1093\/europace\/euac021","article-title":"Watchman FLX vs. Watchman 2.5 in a dual-center left atrial appendage closure cohort: the WATCH-DUAL study","volume":"24","author":"Galea","year":"2022","journal-title":"EP Europace"},{"key":"10.1016\/j.jjcc.2025.12.004_bb0260","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1136\/bmj.311.7003.485","article-title":"Statistics notes: Absence of evidence is not evidence of absence","volume":"311","author":"Altman","year":"1995","journal-title":"BMJ"},{"key":"10.1016\/j.jjcc.2025.12.004_bb0265","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g2215","article-title":"Trap of trends to statistical significance: likelihood of near significant P value becoming more significant with extra data","volume":"348","author":"Wood","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.jjcc.2025.12.004_bb0270","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.jacc.2023.08.010","article-title":"Network meta-analysis of initial antithrombotic regimens after left atrial appendage occlusion","volume":"82","author":"PEP","year":"2023","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S091450872500303X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S091450872500303X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T01:41:43Z","timestamp":1785548503000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S091450872500303X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S091450872500303X"],"URL":"https:\/\/doi.org\/10.1016\/j.jjcc.2025.12.004","relation":{},"ISSN":["0914-5087"],"issn-type":[{"value":"0914-5087","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Watchman FLX versus Amplatzer amulet for percutaneous left atrial appendage occlusion: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jjcc.2025.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Japanese College of Cardiology. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}